|
|
2023's Stock Market Performance
|
|
2023's Stock Market Performance
|
2023's Large Cap Stocks Performance
Here are the best and worst performing Large-Cap Stocks of 2023.
The Large-Cap Company is defined with the market capitalization, trading above 5 billion dollars U.S. as of 10/04/26.
2023's Mid Cap Stocks Performance
Here are the best and worst performing companies of 2023 with the market capitalization, trading between 500 million U.S. dollars and 5 billion dollars U.S. respectively, as of 10/04/26.
2023's Small Cap Stocks Performance
The table shows the best and worst performing companies of 2023 with the market capitalization, trading between 50 million U.S. dollars and 500 million dollars U.S. respectively, as of 10/04/26.
2023's Micro Cap Stocks Performance
The list shows the best and worst performing companies of 2023 with the market capitalization, trading under 50 million U.S. dollars, as of 10/04/26.
Who are the 2023's Stock Market Losers?
REVB
-92.70%
|
|
|
Revelation Biosciences Inc
Major Pharmaceutical Preparations Industry
REVB
-92.70%
Revelation Biosciences Inc*s business model focuses on developing innovative therapies and technologies for various medical conditions.
|
AREB
-93.30%
|
|
|
American Rebel Holdings Inc
Miscellaneous Fabricated Products Industry
AREB
-93.30%
American Rebel Holdings Inc operates as a lifestyle brand company, specializing in the design and distribution of innovative, high-quality products in the outdoor, tactical, and personal protection markets. They aim to provide unique and functional items that cater to their customers* needs and preferences, promoting an adventurous and independent lifestyle.
|
CAMP
-94.41%
|
|
|
Camp4 Therapeutics Corporation
Major Pharmaceutical Preparations Industry
CAMP
-94.41%
Calamp Corp is a technology company that specializes in providing wireless communication solutions and services. They offer a wide range of products, including telematics devices, software platforms, and mobile resource management solutions, catering to various industries such as transportation, logistics, and industrial sectors.
|
TGL
-94.57%
|
|
|
Treasure Global Inc
Professional Services Industry
TGL
-94.57%
Treasure Global Inc operates as a global conglomerate, primarily focused on acquiring and managing diverse businesses across various industries, with an aim to generate long-term value and profitability. Their business model involves strategic acquisitions, careful management of acquired businesses, and leveraging synergies among different subsidiaries to drive growth and maximize shareholder value.
|
SISI
-94.91%
|
|
|
Shineco Inc
Agricultural Production Industry
SISI
-94.91%
Shineco Inc*s business model revolves around cultivating and processing traditional Chinese medicinal herbs and other agricultural products, which are then marketed and sold both domestically and internationally. They aim to leverage their expertise in herbal agriculture to meet the increasing demand for natural, healthy, and sustainable products.
|
GRI
-95.38%
|
|
|
Gri Bio Inc
Major Pharmaceutical Preparations Industry
GRI
-95.38%
Gri Bio Inc*s business model focuses on providing innovative biotechnology solutions.
|
MNTS
-96.02%
|
|
|
Momentus Inc
Aerospace & Defense Industry
MNTS
-96.02%
Momentus Inc is a company that provides in-space transportation services, specializing in delivering satellites and other payloads to specific orbits in space.
|
XTIA
-96.82%
|
|
|
Xti Aerospace Inc
Cloud Computing & Data Analytics Industry
XTIA
-96.82%
XTI Aerospace offers unmanned aerial systems solutions through its commercial and defense divisions.
|
YYAI
-97.70%
|
|
|
Airwa Inc
Recreational Products Industry
YYAI
-97.70%
Connexa Sports Technologies licenses AI-powered matchmaking technology through its subsidiary, YYEM.
|
WHLR
-97.84%
|
|
|
Wheeler Real Estate Investment Trust Inc
Real Estate Investment Trusts Industry
WHLR
-97.84%
Wheeler Real Estate Investment Trust Inc operates as a real estate investment trust focused on the acquisition, development, leasing, and management of retail properties. Their business model revolves around owning and managing a diversified portfolio of retail properties, generating rental income from tenants, and seeking opportunities to enhance property value through strategic leasing and development. They aim to provide stable cash flows and long-term value to their shareholders through well-located and well-managed commercial real estate assets.
|
HUBC
-97.98%
|
|
|
Hub Cyber Security Ltd
Computer Networks Industry
HUBC
-97.98%
Hub Cyber Security Ltd*s business model focuses on providing comprehensive cybersecurity solutions and services to businesses and organizations.
|
EMPD
-98.06%
|
|
|
Empery Digital Inc
EV, Auto & Truck Manufacturers Industry
EMPD
-98.06%
Empery Digital Inc. pursues a digital asset treasury strategy focused on Bitcoin and previously sold electric off-road vehicles.
|
XXII
-98.64%
|
|
|
22nd Century Group inc
Tobacco Industry
XXII
-98.64%
22nd Century Group Inc is a company that operates in various sectors, including plant biotechnology, tobacco, cannabis, and hemp. They focus on developing and commercializing unique technology and products related to genetics, plant breeding, and agricultural science.
|
RNAZ
-98.73%
|
|
|
Transcode Therapeutics Inc
Major Pharmaceutical Preparations Industry
RNAZ
-98.73%
Transcode Therapeutics Inc*s business model revolves around developing innovative RNA-based therapies to treat a wide range of diseases. By leveraging their expertise in mRNA biology and proprietary drug delivery technology, they aim to create transformative treatments with optimized safety and efficacy profiles.
|
DVLT
-98.80%
|
|
|
Datavault Ai Inc
Semiconductors Industry
DVLT
-98.80%
Datavault AI Inc. licenses patented platforms designed for secure data management and monetization.
|
BDRX
-99.12%
|
|
|
Biodexa Pharmaceuticals Plc
Major Pharmaceutical Preparations Industry
BDRX
-99.12%
Biodexa Pharmaceuticals Plc operates as a biopharmaceutical company that focuses on the research, development, and commercialization of innovative medical solutions. Their business model revolves around leveraging scientific expertise to bring new medicines to market and meet the healthcare needs of patients worldwide.
|
|
88.03 %
PREV.